Boron × 睪固酮(提升 / 男性荷爾蒙)

結論:證據支持但有警示

證據強度屬「薄弱」(C 級):唯一直接男性試驗 Naghii 2011(n=8,10 mg/日 × 7 天,open-label 單組)顯示游離睪固酮短暫上升 28%,但無對照組、樣本極小、僅為 7 天代用生化指標(surrogate biomarker),不能視為有效療法。

C 🟠 C 薄弱證據 附警語發布 low — community discussion mostly non-commercial
⚠️ 標記 ⚠️ stale 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

證據強度屬「薄弱」(C 級):唯一直接男性試驗 Naghii 2011(n=8,10 mg/日 × 7 天,open-label 單組)顯示游離睪固酮短暫上升 28%,但無對照組、樣本極小、僅為 7 天代用生化指標(surrogate biomarker),不能視為有效療法。

Nielsen 1987/1996(n=12 停經後女性,由硼缺乏狀態回補)所觀察到的睪固酮上升,是在女性、低硼飲食回補的特殊情境,無法外推到性腺功能正常男性。

Naghii 1994(n=28 年輕女性)甚至為陰性結果。

Examine 給予 Grade C 與本評估完全一致;目前 PubMed 無任何在性腺功能正常男性、以臨床終點(性慾、勃起、肌力、生育力)為主要結果、為期 ≥12 週的 RCT,亦無 meta-analysis。

AUA 2018 與 Endocrine Society 2018 兩大男性低睪固酮主流指引全文未提及硼。

EFSA 在 Article 13(1) 評估中明確以「因果關係未建立」拒絕「硼維持正常血漿睪固酮濃度」之健康宣稱。

整體屬於「機轉訊號 + 極薄弱人體證據」,符合 C 級錨點。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.40
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 附警語發布
信心度
75%
證據方向大致一致
證據層級
E6
多篇較小型隨機對照試驗

各層「支持此療效」的程度

分數越低=該層越不支持
L2 PubMed原始文獻
0.40
L5 臨床機構權威立場
0.40
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L11 AI 複核獨立判讀
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.4
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines
PMID: 21129941 2011 RCT (open-label) n = 8
結論:After 1 week, mean free testosterone rose from 11.83 to 15.18 pg/mL (~28%) and total testosterone trended upward, while estradiol declined and inflammatory cytokines (hsCRP, TNF-alpha, IL-6) decreased. No clinical endpoint measured. Sample size n=8, no placebo arm, 7-day duration — hypothesis-generating only.
🟠 品質有限 學術資助 效應量:Free T +28% over 7 days in n=8, no control arm; surrogate biomarker only
前往 PubMed
Nothing Boring About Boron
PMID: 26770156 2015 Other
結論:Author asserts boron raises free testosterone and reduces inflammation, citing Naghii 2011 (n=8) and small bodybuilder/postmenopausal-women studies. Review is narrative (not systematic), cites only small surrogate-biomarker studies, contains no meta-analytic synthesis and no RCT with clinical endpoint. Frequently cited in supplement marketing despite limited primary evidence.
🟠 品質有限 學術資助 效應量:Narrative claim only; no pooled estimate; underlying primary evidence remains n<10 surrogate studies
前往 PubMed
Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women (Nielsen 1987 FASEB)
PMID: 3678698 1987 Other n = 12
結論:Original report describing serum estradiol approximately doubling and testosterone roughly doubling in postmenopausal women after boron repletion from a deficient state. This is the most-cited primary source in supplement marketing claims, but: (1) cohort is postmenopausal women, NOT men; (2) baseline diet was boron-deficient; (3) n=12 with no placebo arm. Does NOT establish that supplementing boron in eugonadal men produces clinically meaningful testosterone elevation.
🟠 品質有限 政府資助 效應量:~Doubling of serum testosterone in postmenopausal women repleted from boron deficiency; cannot extrapolate to eugonadal men
前往 PubMed
Effects of boron supplementation on blood and urinary calcium, magnesium, and phosphorus, and urinary boron in athletic and sedentary women
PMID: 7840072 1994 隨機對照試驗 n = 28
結論:No significant effect of 3 mg/day boron supplementation on serum testosterone or estradiol in young women. Small sample, female-only, and short duration. Often cited alongside Naghii but reports a null result on sex steroids.
🟠 品質有限 學術資助 效應量:Null on serum testosterone; no significant between-group difference
前往 PubMed
Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women (Nielsen 1987 FASEB)
PMID: 3678698 1987 Other n = 12
結論:Original report describing serum estradiol approximately doubling and testosterone roughly doubling in postmenopausal women after boron repletion from a deficient state. This is the most-cited primary source in supplement marketing claims, but: (1) cohort is postmenopausal women, NOT men; (2) baseline diet was boron-deficient; (3) n=12 with no placebo arm. Does NOT establish that supplementing boron in eugonadal men produces clinically meaningful testosterone elevation.
🟠 品質有限 政府資助 效應量:~Doubling of serum testosterone in postmenopausal women repleted from boron deficiency; cannot extrapolate to eugonadal men
前往 PubMed

L4a US FDA
未表態
Because the FNB has not established an RDA or AI for boron, boron does not have a DV. 來源↗
L4b EU EFSA
謹慎
The Panel concludes that a cause and effect relationship has not been established between the dietary intake of boron and maintenance of normal bone, normal testosterone concentrations in plasma, or maintenance of joint function. Tolerable Upper Intake Level for boron in adults: 10 mg/day (as boric acid equivalents). 來源↗
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
謹慎
基於硼砂對人體的危害,世界上許多國家包括臺灣都已禁止硼砂在食品保存與防腐中使用。 來源↗
L4e WHO
謹慎
Dietary supplements that exceed the TI should be avoided. The TI should be applied with the understanding that boron may provide a physiological benefit for human health. 來源↗

L5a NIH Office of Dietary Supplements
謹慎
Although boron is not classified as an essential nutrient for humans, it might have beneficial effects on bone formation and maintenance, wound healing, the function of steroid hormones (including vitamin D and estrogen), and brain function. Boron is not known to have any clinically relevant interactions with medications. 來源↗
L5b Mayo Clinic
謹慎
Boron supplementation cannot be recommended on the basis of current research. Its basic role in metabolism of bone and the reproductive system remains unclear. Boron might act like estrogen. If you have any condition that might be made worse by exposure to estrogen, avoid supplemental boron or high amounts of boron from foods. 來源↗
L5c Cleveland Clinic
謹慎
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態
We recommend testosterone therapy in hypogonadal men to induce and maintain secondary sex characteristics and correct symptoms of testosterone deficiency. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 低度
📍立場總覽

硼在台灣社群屬冷門題材,僅在 PTT MuscleBeach/MenTalk 睪固酮串中被零星附帶提及(多與鋅一起被列為「可以補充看看」的微量元素),沒有以硼為主題的實測心得、品牌共識或副作用回饋。台灣提升睪固酮的社群討論幾乎都集中在鋅、ZMA、蒺藜、D-天門冬胺酸、瑪卡與直接 TRT(針劑/口服+AI 控雌激素),單獨討論硼的聲量極低。整體可視為 not_addressed 級別的薄弱訊號。

💬社群實感

無共識(台灣社群幾無針對硼的實測心得,僅與鋅併列被零星提及)

破解迷思 社群最常見的 3 個誤解
事實把國外「10mg 硼 7 天提升 28% 游離睪固酮」的單一小型研究,當成硼對所有人都有顯著補睪效果(社群少有人實測證實,且該數據常被保健媒體誇大引用)
事實誤以為硼是台灣健身圈主流的天然補睪成分(實際社群討論度遠低於鋅、ZMA、蒺藜、瑪卡,硼僅屬冷門附帶提及)
事實把硼與微量元素鋅混為一談、或誤以為兩者效果與機轉相同

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

PBF 寶齡富錦 胺基酸螯合鈣+硼+鎂 (45錠/盒) $442

代表來源 ↗
L10b · TFDA 法定身份 官方認定

甘胺酸硼(Boron Glycinate):形態屬膠囊狀、錠狀且標示有每日食用限量之食品,在每日食用量中,其硼之總含量不得高於700 μg。限於補充食品中不足之營養素時使用。

來源 ↗

  • 睪固酮補充療法
  • 減重與運動等生活型態調整
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 5 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v29 engine_version: v1.0 claim_id: CLM-COND-testosterone-INT-boron-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-testosterone-INT-boron-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "硼能改善睪固酮(提升 / 男性荷爾蒙)",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}